Brazil's health regulator, Brazilian National Health Surveillance Agency (Anvisa), has declined to approve the Russia-developed Sputnik V for emergency use because of some missing data.
Johnson & Johnson's experimental one-shot COVD-19 vaccine showed promise in an early safety study as the company gets closer to coming to U.S. regulators for clearance.
Several Latino education and civil rights groups are asking President-elect Joe Biden to push back in-person English-language testing to protect the students from COVID-19.
There are many things you have to look out for when it comes to coronavirus infection. But some of those already infected by the virus may not be aware that they could get one permanent COVID-19 symptom.
The state of Florida's COVID-19 vaccine rollout has been met with various challenges, ranging from supply issues, communication challenges, and disordered distribution plans.
The U.S. Centers for Disease Control and Prevention (CDC) clarified there is no "USA variant" of COVID-19, contradicting the White House coronavirus task force's report on such variant.
Dr. Anthony Fauci, the nation's top infectious disease expert, predicted on Thursday that the COVID-19 pandemic in the U.S. would continue to get worse in the weeks to come.
A new study focusing on COVID-19 immunity study that was recently published by the Centers for Disease Control and Prevention suggests that asymptomatic patients and those with mild COVID-19 cases will develop strong immune responses that can be traced through antibody tests.
Researchers said Thursday that the Sinovac, the COVID-19 vaccine developed by a Chinese firm, was 78 percent effective in a late-stage Brazilian trial, but experts ask for more details.
